- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of ketamine and its metabolites as antidepressants
Authors
Keywords
Ketamine, (, 2R,6R, )-Hydroxynorketamine, Antidepressant, Glutamate, Depression, NMDAR
Journal
BIOCHEMICAL PHARMACOLOGY
Volume 197, Issue -, Pages 114892
Publisher
Elsevier BV
Online
2021-12-27
DOI
10.1016/j.bcp.2021.114892
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketamine and the Future of Rapid-Acting Antidepressants
- (2021) Lace M. Riggs et al. Annual Review of Clinical Psychology
- Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
- (2021) Plinio C. Casarotto et al. CELL
- Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
- (2021) Jaclyn N. Highland et al. PHARMACOLOGICAL REVIEWS
- Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors
- (2021) Thomas T. Joseph et al. ACS Chemical Neuroscience
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
- (2021) Jordi Bonaventura et al. MOLECULAR PSYCHIATRY
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)
- (2021) Paul E. Greenberg et al. PHARMACOECONOMICS
- Striatal dopamine mediates hallucination-like perception in mice
- (2021) K. Schmack et al. SCIENCE
- Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial
- (2021) Anna Höflich et al. Translational Psychiatry
- Structural basis of ketamine action on human NMDA receptors
- (2021) Youyi Zhang et al. NATURE
- Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice
- (2021) Fan Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Family of Structurally Related Bioconjugates Yields Antibodies with Differential Selectivity against Ketamine and 6-Hydroxynorketamine
- (2021) Zhen Zheng et al. ACS Chemical Neuroscience
- Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
- (2021) Kasper B. Hansen et al. PHARMACOLOGICAL REVIEWS
- Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents
- (2020) Matthew E. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines
- (2020) Farhan Ali et al. Nature Communications
- A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression
- (2020) Mikael Tiger et al. Translational Psychiatry
- Hydroxynorketamine Blocks N-Methyl-d-Aspartate Receptor Currents by Binding to Closed Receptors
- (2020) Jamie A. Abbott et al. MOLECULAR PHARMACOLOGY
- Cell-type specific modulation of NMDA receptors triggers antidepressant actions
- (2020) Santosh Pothula et al. MOLECULAR PSYCHIATRY
- Brain-derived neurotrophic factor in the ventrolateral periaqueductal gray contributes to (2R,6R)-hydroxynorketamine-mediated actions
- (2020) Dylan Chou NEUROPHARMACOLOGY
- Genome-wide association study and polygenic risk score analysis of esketamine treatment response
- (2020) Qingqin S. Li et al. Scientific Reports
- Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
- (2020) Melodi A. Bowman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Improving translation of animal models of addiction and relapse by reverse translation
- (2020) Marco Venniro et al. NATURE REVIEWS NEUROSCIENCE
- Positive modulation of NMDA receptors by AGN-241751 exerts rapid antidepressant-like effects via excitatory neurons
- (2020) Santosh Pothula et al. NEUROPSYCHOPHARMACOLOGY
- Correction: R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2020) C. Yang et al. Translational Psychiatry
- Antidepressant actions of ketamine engage cell-specific translation via eIF4E
- (2020) Argel Aguilar-Valles et al. NATURE
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder
- (2019) Gihyun Yoon et al. JAMA Psychiatry
- (2R,6R)-hydroxynorketamine exerts mGlu2receptor-dependent antidepressant actions
- (2019) Panos Zanos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
- (2019) Eric W. Lumsden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity
- (2019) Nathalie Picard et al. MOLECULAR PSYCHIATRY
- Concurrent Use of Buprenorphine, Methadone, or Naltrexone Does Not Inhibit Ketamine’s Antidepressant Activity
- (2019) Tobias Marton et al. BIOLOGICAL PSYCHIATRY
- No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples
- (2019) Richard Border et al. AMERICAN JOURNAL OF PSYCHIATRY
- Target Population, Dose, and Timing Considerations for Understanding Naltrexone’s Subjective Effect: Response to Amiaz
- (2019) Boris D. Heifets et al. AMERICAN JOURNAL OF PSYCHIATRY
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism: Is It a Ketamine-Specific Effect?
- (2019) Revital Amiaz AMERICAN JOURNAL OF PSYCHIATRY
- Interpreting Ketamine’s Opioid Receptor Dependent Effect: Response to Sanacora
- (2019) Boris D. Heifets et al. AMERICAN JOURNAL OF PSYCHIATRY
- Caution Against Overinterpreting Opiate Receptor Stimulation as Mediating Antidepressant Effects of Ketamine
- (2019) Gerard Sanacora AMERICAN JOURNAL OF PSYCHIATRY
- ( R )‐Ketamine exerts antidepressant actions partly via conversion to ( 2R,6R )‐hydroxynorketamine, while causing adverse effects at sub‐anaesthetic doses
- (2019) Panos Zanos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mechanisms That Modulate and Diversify BDNF Functions: Implications for Hippocampal Synaptic Plasticity
- (2019) Ana Paula De Vincenti et al. Frontiers in Cellular Neuroscience
- Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine’s Antidepressant Effect
- (2019) Boris D. Heifets et al. JAMA Psychiatry
- Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine’s Antidepressant Effect—Reply
- (2019) John H. Krystal et al. JAMA Psychiatry
- Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
- (2019) Xavier López-Gil et al. ACS Chemical Neuroscience
- Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine
- (2019) Christopher L. Shaffer et al. NEUROPHARMACOLOGY
- (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism
- (2019) Lace M. Riggs et al. NEUROPSYCHOPHARMACOLOGY
- Lower synaptic density is associated with depression severity and network alterations
- (2019) Sophie E. Holmes et al. Nature Communications
- Astrocyte Specific Remodeling of Plasmalemmal Cholesterol Composition by Ketamine Indicates a New Mechanism of Antidepressant Action
- (2019) Eva Lasič et al. Scientific Reports
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
- (2019) Yukio Ago et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Classical conditioning of antidepressant placebo effects in mice
- (2019) Samuel R. Krimmel et al. PSYCHOPHARMACOLOGY
- Pharmacologically diverse antidepressants facilitate TRKB receptor activation by disrupting its interaction with the endocytic adaptor complex AP-2
- (2019) Senem Merve Fred et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
- (2019) Danielle M. Gerhard et al. JOURNAL OF CLINICAL INVESTIGATION
- Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
- (2019) Satoshi Deyama et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Intracellular Signaling Pathways Involved in ( S )- and ( R )-Ketamine Antidepressant Actions
- (2018) Panos Zanos et al. BIOLOGICAL PSYCHIATRY
- Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
- (2018) Marta Peciña et al. MOLECULAR PSYCHIATRY
- (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray
- (2018) Dylan Chou et al. NEUROPHARMACOLOGY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
- (2018) Allie J. Widman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- S-Ketamine Mediates Its Acute and Sustained Antidepressant-Like Activity through a 5-HT1B Receptor Dependent Mechanism in a Genetic Rat Model of Depression
- (2018) Kristian G. du Jardin et al. Frontiers in Pharmacology
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Is There Really Nothing New Under the Sun? Is Low-Dose Ketamine a Fast-Acting Antidepressant Simply Because It Is An Opioid?
- (2018) Mark S. George AMERICAN JOURNAL OF PSYCHIATRY
- Depression and Obesity: Integrating the Role of Stress, Neuroendocrine Dysfunction and Inflammatory Pathways
- (2018) Silvia R. S. Ouakinin et al. Frontiers in Endocrinology
- Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
- (2018) Todd D. Gould et al. Annual Review of Pharmacology and Toxicology
- Lack of Opioid System in the Antidepressant Actions of Ketamine
- (2018) Kai Zhang et al. BIOLOGICAL PSYCHIATRY
- Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine
- (2018) Jaclyn N Highland et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The AMPA Receptor Code of Synaptic Plasticity
- (2018) Graham H. Diering et al. NEURON
- Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
- (2018) Kenichi Fukumoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
- (2017) Marie Spies et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Prescription Opioid Use among Adults with Mental Health Disorders in the United States
- (2017) Matthew A. Davis et al. Journal of the American Board of Family Medicine
- Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling
- (2017) L Cavalleri et al. MOLECULAR PSYCHIATRY
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Effects of a ketamine metabolite on synaptic NMDAR function
- (2017) Kanzo Suzuki et al. NATURE
- Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice
- (2017) T.H. Pham et al. NEUROPHARMACOLOGY
- Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites
- (2017) Patrick J. Morris et al. ORGANIC LETTERS
- mGlu2/3 Receptor Antagonists as Novel Antidepressants
- (2017) Shigeyuki Chaki TRENDS IN PHARMACOLOGICAL SCIENCES
- Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses
- (2017) Joana S Ferreira et al. eLife
- Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents
- (2017) Cosima Locher et al. JAMA Psychiatry
- Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence
- (2017) Lars Tanum et al. JAMA Psychiatry
- Ketamine abuse potential and use disorder
- (2016) Yu Liu et al. BRAIN RESEARCH BULLETIN
- Ketamine: NMDA Receptors and Beyond
- (2016) C. F. Zorumski et al. JOURNAL OF NEUROSCIENCE
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
- (2016) Ronald S Duman et al. NATURE MEDICINE
- Synaptic AMPA receptor composition in development, plasticity and disease
- (2016) Jeremy M. Henley et al. NATURE REVIEWS NEUROSCIENCE
- Emerging roles of GluN3-containing NMDA receptors in the CNS
- (2016) Isabel Pérez-Otaño et al. NATURE REVIEWS NEUROSCIENCE
- Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
- (2016) Ashley E. Lepack et al. NEUROPHARMACOLOGY
- Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study
- (2016) Gerard Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine Mechanism of Action: Separating the Wheat from the Chaff
- (2016) Todd D Gould et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors
- (2016) Edgardo Falcon et al. NEUROPSYCHOPHARMACOLOGY
- Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine
- (2016) K. Zhang et al. Science Signaling
- Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine
- (2016) K. Zhang et al. Science Signaling
- Depression and the Link with Cardiovascular Disease
- (2016) Arup K. Dhar et al. Frontiers in Psychiatry
- Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells
- (2016) Nagendra S. Singh et al. PLoS One
- A Randomized Trial of Combined Citalopram and Naltrexone for Nonabstinent Outpatients With Co-Occurring Alcohol Dependence and Major Depression
- (2015) Simon J. Adamson et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- GluN2B-Containing NMDA Receptors Regulate AMPA Receptor Traffic through Anchoring of the Synaptic Proteasome
- (2015) J. S. Ferreira et al. JOURNAL OF NEUROSCIENCE
- The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN
- (2015) Kenichi Fukumoto et al. NEUROPSYCHOPHARMACOLOGY
- An excitatory synapse hypothesis of depression
- (2015) Scott M. Thompson et al. TRENDS IN NEUROSCIENCES
- BDNF Release Is Required for the Behavioral Actions of Ketamine
- (2015) A. E. Lepack et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Restoring Mood Balance in Depression: Ketamine Reverses Deficit in Dopamine-Dependent Synaptic Plasticity
- (2014) Pauline Belujon et al. BIOLOGICAL PSYCHIATRY
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors
- (2014) Daniela da Fonseca Pacheco et al. BRAIN RESEARCH
- Diabetes and Depression
- (2014) Richard I. G. Holt et al. Current Diabetes Reports
- Comparison of Antidepressant-Like and Abuse-Related Effects of Phencyclidine in Rats
- (2014) Todd M. Hillhouse et al. DRUG DEVELOPMENT RESEARCH
- Downregulation of Neuregulin 1-ErbB4 Signaling in Parvalbumin Interneurons in the Rat Brain May Contribute to the Antidepressant Properties of Ketamine
- (2014) Nan Wang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Loss of Phenotype of Parvalbumin Interneurons in Rat Prefrontal Cortex Is Involved in Antidepressant- and Propsychotic-Like Behaviors Following Acute and Repeated Ketamine Administration
- (2014) ZhiQiang Zhou et al. MOLECULAR NEUROBIOLOGY
- Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
- (2014) Laura Pozzi et al. PLoS One
- Fast-spiking, parvalbumin+ GABAergic interneurons: From cellular design to microcircuit function
- (2014) H. Hu et al. SCIENCE
- A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques
- (2014) H Yamanaka et al. Translational Psychiatry
- Depression as a Risk Factor for Cancer: From Pathophysiological Advances to Treatment Implications
- (2013) M. Beatriz Currier et al. Annual Review of Medicine
- Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule
- (2013) Todd M. Hillhouse et al. BEHAVIOURAL PHARMACOLOGY
- Ketamine for chronic pain: risks and benefits
- (2013) Marieke Niesters et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Antidepressant Augmentation Using theN-Methyl-d-Aspartate Antagonist Memantine
- (2013) Eric G. Smith et al. JOURNAL OF CLINICAL PSYCHIATRY
- Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
- (2013) E. Nosyreva et al. JOURNAL OF NEUROSCIENCE
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression
- (2013) Xiang Cai et al. NATURE NEUROSCIENCE
- NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
- (2013) Pierre Paoletti et al. NATURE REVIEWS NEUROSCIENCE
- Effect of Subanesthetic Ketamine on Intrinsic Functional Brain Connectivity
- (2012) Marieke Niesters et al. ANESTHESIOLOGY
- Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
- (2012) Gonzalo Laje et al. BIOLOGICAL PSYCHIATRY
- Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression
- (2012) Xiaochen Zhao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
- (2012) Ruin Moaddel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- NMDA receptor mediated phosphorylation of GluR1 subunits contributes to the appearance of calcium-permeable AMPA receptors after mechanical stretch injury
- (2012) Jennifer Spaethling et al. NEUROBIOLOGY OF DISEASE
- Time, action and psychosis: Using subjective time to investigate the effects of ketamine on sense of agency
- (2012) J.W. Moore et al. NEUROPSYCHOLOGIA
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
- (2011) Rong-Jian Liu et al. BIOLOGICAL PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Differential regulation of AMPA receptor GluA1 phosphorylation at serine 831 and 845 associated with activation of NMDA receptor subpopulations
- (2011) Heng Ai et al. NEUROSCIENCE LETTERS
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade
- (2011) Tomi Rantamäki et al. PLoS One
- Ketamine perturbs perception of the flow of time in healthy volunteers
- (2011) Jennifer T Coull et al. PSYCHOPHARMACOLOGY
- A Double-Blind, Placebo-Controlled Trial Combining Sertraline and Naltrexone for Treating Co-Occurring Depression and Alcohol Dependence
- (2010) Helen M. Pettinati et al. AMERICAN JOURNAL OF PSYCHIATRY
- Taming the Ketamine Tiger
- (2010) Edward F. Domino ANESTHESIOLOGY
- The Brainstem Noradrenergic Systems in Stress, Anxiety and Depression
- (2010) K. Itoi et al. JOURNAL OF NEUROENDOCRINOLOGY
- Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
- (2010) Ethan S. Bromberg-Martin et al. NEURON
- Glutamate Receptor Ion Channels: Structure, Regulation, and Function
- (2010) S. F. Traynelis et al. PHARMACOLOGICAL REVIEWS
- Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
- (2010) Christina L. Nemeth et al. PSYCHOPHARMACOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- A parallel chiral–achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome
- (2010) Ruin Moaddel et al. TALANTA
- Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation
- (2009) H. Jourdi et al. JOURNAL OF NEUROSCIENCE
- Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
- (2009) S. E. Kotermanski et al. JOURNAL OF NEUROSCIENCE
- TrkB signalling pathways in LTP and learning
- (2009) Liliana Minichiello NATURE REVIEWS NEUROSCIENCE
- Serotonin Receptors
- (2008) David E. Nichols et al. CHEMICAL REVIEWS
- Serotonin research: contributions to understanding psychoses
- (2008) M GEYER et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started